FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the first medication for certain patients with the condition.
Eli Lilly’s stock falls as weight-loss drug sales disappoint
Shares of Eli Lilly and Co. slipped 0.4% in premarket trading Tuesday, after the drug maker provided a disappointing fourth-quarter revenue outlook, citing slower-than-expected growth in sales of its weight-loss drugs.
Eli Lilly CEO tells Bloomberg TV company sees weight loss pill approval in 2026
Eli Lilly (LLY) expects that its experimental weight loss pill will get approved as soon as early next year, CEO David Ricks said in an
Eli Lilly's weight loss pill could get federal approval by early next year
Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron, is expected before the middle of 2025.
Eli Lilly Stumbled But Weight-Loss Drugs Will Continue to Fuel Markets. Here’s Why and 5 Other Things to Know Today.
SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start your day.
Eli Lilly was hoping weight loss drug demand would be even bigger
Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its popular weight-loss drugs, Zepbound and Mounjaro.
Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow
Eli Lilly stock fell on lowered Q4 guidance amid slower-than-expected sales for its Zepbound and Mounjaro weight loss drugs.
Hosted on MSN2d
Mitolyn Reviews (SCAM ALERT) Is It A Safe Weight Loss Supplement To Try Or Serious Customer Complaints? (2025 WARNING)
Mitolyn is a newly introduced weight management supplement that claims to unlock the body’s metabolic potential. According to ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
The Georgia Straight17d
Top 6 Best OTC Weight Loss Supplements in 2025
However, it is important to note that no supplement can replace a healthy diet and exercise routine. Which weight loss pill is FDA-approved? The only FDA-approved weight loss pill ...
Forbes3d
Are Weight Loss Injections Effective?
Many providers are familiar with the latest weight-loss injections, but not all individuals are candidates for these prescription injections, says Dr. Millard. Ozempic is an FDA-approved ...
Fox News23d
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
called the FDA’s approval a "promising advancement for the millions of people who suffer from this condition." "Zepbound promotes weight loss and has been shown to reduce apnea events." ...
WFAE26d
FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
The weight loss ... FDA's Center for Drug Evaluation and Research, in a statement. The federal approval does not come as a complete surprise, as doctors have long recommended that maintaining ...
Onlymyhealth17d
FDA Approves Weight-Loss Drug Zepbound For Obstructive Sleep Apnea
The U.S. Food and Drug Administration (FDA ... improving overall health. The approval of Zepbound underscores the evolving landscape of OSA management, combining weight-loss benefits with ...
Hosted on MSN2d
Purple Peel Exploit: Revolutionizing Weight Loss with Natural Ingredients and Science-Backed Benefits
In today's fast-paced world, finding an effective weight loss solution can often feel like searching for a needle in a ...